PMID: 9437628Jan 23, 1998Paper

Drug abuse treatment process components that improve retention

Journal of Substance Abuse Treatment
D D SimpsonJ M Greener

Abstract

Longer retention has been the most consistent predictor of favorable drug abuse treatment outcomes, but key therapeutic and patient engagement indicators of treatment process need to be more clearly established. An integrative model representing treatment dynamics was tested for explaining long-term program retention. It was based on a multisite sample of 527 daily opioid users who remained in methadone maintenance a minimum of 3 months. All had been assigned randomly to a counseling condition at admission (i.e., cognitively enhanced or standard), and information obtained from patient files, as well as periodic assessments completed by patients and their counselors in the first 90 days after admission were the sources of predictors. Counseling enhancements (using node-link mapping, a visual representation tool for improving communication and problem solving) contributed to stronger therapeutic relationships between counselor and patient, which in turn had a positive reciprocal relationship with patient engagement (session attendance). Pretreatment motivation measured at intake was also related to higher engagement. More positive therapeutic relationships (in months 1 and 2) led to lower levels of during-treatment drug use (defi...Continue Reading

References

Jul 1, 1979·Archives of General Psychiatry·D D SimpsonM R Lloyd
Sep 1, 1992·The American Psychologist·J O ProchaskaJ C Norcross
Jan 8, 1992·JAMA : the Journal of the American Medical Association·T D'Aunno, T E Vaughn
Jan 1, 1991·Journal of Substance Abuse·G W JoeR L Hubbard
Jan 1, 1989·The American Journal of Drug and Alcohol Abuse·E P Nace
Jun 1, 1985·The International Journal of the Addictions·G De Leon
Mar 1, 1995·The International Journal of the Addictions·D F DansereauD D Simpson
Jan 1, 1995·Journal of Substance Abuse·D D SimpsonJ Greener
Jan 1, 1994·Journal of Substance Abuse·G W JoeD D Simpson
Jan 1, 1995·The International Journal of the Addictions·G De Leon
Jan 1, 1996·Journal of Substance Abuse·D K Knight, D D Simpson
May 1, 1997·The Journal of Nervous and Mental Disease·G W JoeD D Simpson
Nov 5, 1997·Drug and Alcohol Dependence·D D SimpsonG A Rowan-Szal

❮ Previous
Next ❯

Citations

Jun 28, 2008·The Journal of Behavioral Health Services & Research·Melissa A Walker
Mar 12, 2003·Addictive Behaviors·Michael Czuchry, Donald F Dansereau
Mar 22, 2002·Drug and Alcohol Dependence·Marjorie F GoldsteinStephen Magura
Jun 25, 2003·Drug and Alcohol Dependence·Michael GossopJohn Marsden
Nov 5, 1997·Drug and Alcohol Dependence·D D SimpsonG A Rowan-Szal
Jan 5, 2000·Drug and Alcohol Dependence·K M BroomeG W Joe
Jan 5, 2000·Drug and Alcohol Dependence·G W JoeK M Broome
Aug 30, 2000·Journal of Substance Abuse Treatment·M A Lang, S Belenko
Apr 18, 2001·Journal of Substance Abuse Treatment·H SungL Feng
Oct 24, 2001·Journal of Substance Abuse Treatment·G H De Weert-Van OeneG J Schrijvers
Sep 12, 2001·Journal of Substance Abuse Treatment·P D FriedmannM D Stein
Jun 20, 2002·Journal of Substance Abuse Treatment·George W JoeD Dwayne Simpson
Dec 13, 2003·Journal of Substance Abuse Treatment·Bennett W FletcherPatrick M Flynn
Dec 31, 2003·Journal of Substance Abuse Treatment·Hung-En SungCarrie Tabachnick
Dec 25, 2003·Journal of Substance Abuse Treatment·Kyle BeardsleyAmelia M Arria
Jun 27, 2000·Journal of Substance Abuse Treatment·J E SchumacherC McNamara
Jun 27, 2000·Journal of Substance Abuse Treatment·G A Rowan-SzalD D Simpson
Mar 24, 2005·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Ronda L DearingKimberly S Walitzer
Jun 15, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chris C StreeterDeborah A Yurgelun-Todd
May 11, 2002·Journal of Psychoactive Drugs·Clare SearsJoseph Guydish
Aug 21, 2007·Journal of Psychoactive Drugs·Gerald J StahlerMaryLouise E Kerwin
Aug 27, 2009·Journal of Psychoactive Drugs·Jean Oggins
Dec 17, 2009·Journal of Psychoactive Drugs·Yali AbramsohnMiriam Adelson
Feb 7, 2009·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Soheil SolimanJeffrey A Alexander
Oct 22, 2011·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Scott DeMuroRachel Anderson
Jun 23, 2001·Journal of Urban Health : Bulletin of the New York Academy of Medicine·B E RichieJ Page
Apr 29, 2008·Harm Reduction Journal·Alex StevensNeil Hunt
Jan 5, 2001·Social Work in Health Care·M ComfortK Kaltenbach
Mar 18, 2006·European Addiction Research·G H De Weert-Van OeneC A J de Jong
Mar 16, 2007·European Addiction Research·G H de Weert-van OeneA J P Schrijvers
Apr 9, 2008·Substance Use & Misuse·Albert M WoodwardBeatrice Blacklow
Jun 13, 2013·Journal of Substance Abuse Treatment·Meeyoung O MinAlexandre Laudet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.